AU2883900A - Secreted and transmembrane polypeptides and nucleic acids encoding the same - Google Patents
Secreted and transmembrane polypeptides and nucleic acids encoding the sameInfo
- Publication number
- AU2883900A AU2883900A AU28839/00A AU2883900A AU2883900A AU 2883900 A AU2883900 A AU 2883900A AU 28839/00 A AU28839/00 A AU 28839/00A AU 2883900 A AU2883900 A AU 2883900A AU 2883900 A AU2883900 A AU 2883900A
- Authority
- AU
- Australia
- Prior art keywords
- secreted
- same
- nucleic acids
- acids encoding
- transmembrane polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (32)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14304899P | 1999-07-07 | 1999-07-07 | |
| US60/143048 | 1999-07-07 | ||
| US14569899P | 1999-07-26 | 1999-07-26 | |
| US60/145698 | 1999-07-26 | ||
| US14622299P | 1999-07-28 | 1999-07-28 | |
| US60/146222 | 1999-07-28 | ||
| WOUS99/20594 | 1999-09-08 | ||
| PCT/US1999/020594 WO2000015666A2 (en) | 1998-09-10 | 1999-09-08 | Compositions and methods for the treatment of tumors |
| PCT/US1999/020944 WO2000015792A2 (en) | 1998-09-14 | 1999-09-13 | Promotion or inhibition of angiogenesis and cardiovascularization |
| WOUS99/20944 | 1999-09-13 | ||
| PCT/US1999/021090 WO2000015796A2 (en) | 1998-09-16 | 1999-09-15 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WOUS99/21090 | 1999-09-15 | ||
| WOUS99/21547 | 1999-09-15 | ||
| PCT/US1999/021547 WO2000015797A2 (en) | 1998-09-17 | 1999-09-15 | Compositions and methods for the treatment of immune related diseases |
| PCT/US1999/023089 WO2000021996A2 (en) | 1998-10-13 | 1999-10-05 | Methods and compositions for inhibiting neoplastic cell growth |
| WOUS99/23089 | 1999-10-05 | ||
| PCT/US1999/028214 WO2001019987A1 (en) | 1999-09-13 | 1999-11-29 | Promotion or inhibition of angiogenesis and cardiovascularization |
| WOUS99/28214 | 1999-11-29 | ||
| PCT/US1999/028313 WO2000032221A2 (en) | 1998-12-01 | 1999-11-30 | Promotion or inhibition of angiogenesis and cardiovascularization |
| WOUS99/28313 | 1999-11-30 | ||
| PCT/US1999/028565 WO2000037638A2 (en) | 1998-12-22 | 1999-12-02 | Methods and compositions for inhibiting neoplastic cell growth |
| PCT/US1999/028564 WO2000055319A1 (en) | 1999-03-12 | 1999-12-02 | Methods and compositions for inhibiting neoplastic cell growth |
| WOUS99/28565 | 1999-12-02 | ||
| WOUS99/28564 | 1999-12-02 | ||
| WOUS99/30095 | 1999-12-16 | ||
| PCT/US1999/030095 WO2000037640A2 (en) | 1998-12-22 | 1999-12-16 | Compositions and methods for the treatment of tumor |
| PCT/US1999/030999 WO2001005836A1 (en) | 1999-07-20 | 1999-12-20 | Polypeptidic compositions and methods for the treatment of tumors |
| PCT/US1999/030911 WO2000075316A1 (en) | 1999-06-02 | 1999-12-20 | Methods and compositions for inhibiting neoplastic cell growth |
| WOUS99/30999 | 1999-12-20 | ||
| WOUS99/30911 | 1999-12-20 | ||
| WOUS99/00219 | 2000-01-05 | ||
| PCT/US2000/004414 WO2001004311A1 (en) | 1999-07-07 | 2000-02-22 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2883900A true AU2883900A (en) | 2001-01-30 |
Family
ID=56289994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28839/00A Abandoned AU2883900A (en) | 1999-07-07 | 2000-02-22 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2883900A (en) |
| WO (1) | WO2001004311A1 (en) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7057017B2 (en) | 1997-04-16 | 2006-06-06 | Millennium Pharmaceuticals, Inc. | Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| US7169906B2 (en) | 1997-09-17 | 2007-01-30 | Genentech, Inc. | PRO211 polypeptides |
| US6974689B1 (en) | 1997-09-18 | 2005-12-13 | Genentech, Inc. | Nucleic acid encoding PRO211 polypeptides |
| US8088386B2 (en) | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
| US7192589B2 (en) | 1998-09-16 | 2007-03-20 | Genentech, Inc. | Treatment of inflammatory disorders with STIgMA immunoadhesins |
| US8007798B2 (en) | 1997-11-21 | 2011-08-30 | Genentech, Inc. | Treatment of complement-associated disorders |
| US7419663B2 (en) | 1998-03-20 | 2008-09-02 | Genentech, Inc. | Treatment of complement-associated disorders |
| US7446181B2 (en) | 1998-01-15 | 2008-11-04 | Millennium Pharmaceuticals, Inc. | Antibodies that bind human Dickkopf-1 proteins |
| US6344541B1 (en) | 1998-09-25 | 2002-02-05 | Amgen Inc. | DKR polypeptides |
| US6902892B1 (en) | 1998-10-19 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| DE10106835A1 (en) * | 2001-02-14 | 2002-09-05 | Basf Lynx Bioscience Ag | Signal transduction proteins 15B3, 15B3-1 and 15B3-2 and underlying DNA sequences |
| US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
| AU2002333862A1 (en) * | 2001-09-20 | 2003-04-01 | Bayer Aktiengesellschaft | Regulation of human prolyl 4-hydroxylase alpha subunit precursor |
| AU2003227179A1 (en) * | 2002-02-08 | 2003-09-09 | Amersham Biosciences K.K. | Fused protein having glucuronyl transferase activity |
| EP1491628A4 (en) * | 2002-03-29 | 2006-10-18 | Nat Inst Of Advanced Ind Scien | NOVEL GALACTOSE TRANSFERASES AND THEIR PEPTIDES, AND NUCLEIC ACID ENCODING THE SAME TRANSFERASES |
| WO2003103725A1 (en) | 2002-06-07 | 2003-12-18 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| WO2004002515A1 (en) * | 2002-06-28 | 2004-01-08 | Takeda Chemical Industries, Ltd. | Diagnostics/preventives/remedies for respiratory diseases |
| DE10254601A1 (en) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Gene products differentially expressed in tumors and their use |
| CA2511556A1 (en) * | 2002-12-27 | 2004-07-29 | Applied Research Systems Ars Holding N.V. | Novel fibrillin-like polypeptides |
| EA010055B1 (en) | 2003-03-19 | 2008-06-30 | Байоджен Айдек Ма Инк. | Isolated nucleic acid encoding sp35 polypeptide, sp35 polypeptide and methods of use nucleic acid and polypeptide |
| MXPA05012957A (en) * | 2003-05-30 | 2006-06-27 | Agensys Inc | Prostate stem cell antigen (psca) variants and subsequences thereof. |
| WO2005019258A2 (en) * | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| DE102004024617A1 (en) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
| WO2006002437A2 (en) | 2004-06-24 | 2006-01-05 | Biogen Idec Ma Inc. | Treatment of conditions involving demyelination |
| AU2005267722B2 (en) | 2004-08-04 | 2009-10-08 | Amgen Inc. | Antibodies to Dkk-1 |
| US7544659B2 (en) | 2004-08-13 | 2009-06-09 | Genentech, Inc. | Promotion of axonal regeneration |
| ES2434470T3 (en) | 2005-07-08 | 2013-12-16 | Biogen Idec Ma Inc. | SP35 antibodies and their uses |
| MX337061B (en) | 2005-11-04 | 2016-02-11 | Genentech Inc | Use of complement pathway inhibitors to treat ocular diseases. |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| MY157948A (en) | 2006-11-02 | 2016-08-30 | Genentech Inc | Humanized anti-factor d antibodies |
| US8128926B2 (en) | 2007-01-09 | 2012-03-06 | Biogen Idec Ma Inc. | Sp35 antibodies and uses thereof |
| AR066660A1 (en) | 2007-05-23 | 2009-09-02 | Genentech Inc | PREVENTION AND TREATMENT OF EYE CONDITIONS ASSOCIATED WITH THEIR COMPLEMENT |
| CR20170001A (en) | 2008-04-28 | 2017-08-10 | Genentech Inc | ANTI FACTOR D HUMANIZED ANTIBODIES |
| EP3141560A3 (en) | 2008-05-06 | 2017-05-24 | Genentech, Inc. | Affinity matured crig variants |
| EP2982695B1 (en) | 2008-07-09 | 2019-04-03 | Biogen MA Inc. | Compositions comprising antibodies to lingo or fragments thereof |
| WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
| AU2013262934B2 (en) | 2012-05-14 | 2018-02-01 | Biogen Ma Inc. | LINGO-2 antagonists for treatment of conditions involving motor neurons |
| CR20160132A (en) | 2013-08-12 | 2016-08-25 | Genentech Inc | COMPOSITIONS AND METHOD TO TREAT CONDITIONS ASSOCIATED WITH THE COMPLEMENT |
| MX2016014160A (en) | 2014-05-01 | 2017-02-16 | Genentech Inc | Anti-factor d antibody variants and uses thereof. |
| WO2016112270A1 (en) | 2015-01-08 | 2016-07-14 | Biogen Ma Inc. | Lingo-1 antagonists and uses for treatment of demyelinating disorders |
| WO2017075173A2 (en) | 2015-10-30 | 2017-05-04 | Genentech, Inc. | Anti-factor d antibodies and conjugates |
| CN108472382A (en) | 2015-10-30 | 2018-08-31 | 豪夫迈·罗氏有限公司 | Anti- factor D antibody variants conjugate and application thereof |
| CN117801091B (en) * | 2023-12-28 | 2024-05-31 | 广东圆康再生医学科技开发有限公司 | Application of endometrial stem cells in endometrial repair |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5707829A (en) * | 1995-08-11 | 1998-01-13 | Genetics Institute, Inc. | DNA sequences and secreted proteins encoded thereby |
| US5824504A (en) * | 1996-09-26 | 1998-10-20 | Elshourbagy; Nabil A. | Human 7-transmembrane receptor and DNA |
| AU9312198A (en) * | 1997-09-17 | 1999-04-05 | Genentech Inc. | Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer |
| JP2001516580A (en) * | 1997-09-17 | 2001-10-02 | ジェネンテック・インコーポレーテッド | Secretory and transmembrane polypeptides and nucleic acids encoding them |
-
2000
- 2000-02-22 WO PCT/US2000/004414 patent/WO2001004311A1/en not_active Ceased
- 2000-02-22 AU AU28839/00A patent/AU2883900A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001004311A1 (en) | 2001-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7573000A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU2055401A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU2883700A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU2883900A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU2001268028A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU2001273150A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU2001265311A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU2002216610A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| IL139686A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| IL188577A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| WO1999046281A8 (en) | Novel polypeptides and nucleic acids encoding the same | |
| IL141535A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU3899700A (en) | Secreted proteins and polynucleotides encoding them | |
| AU7379000A (en) | Secreted proteins and polynucleotides encoding them | |
| AU1453601A (en) | Novel polypeptides and nucleic acids encoding same | |
| KR100514265B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
| AU3006400A (en) | Secreted proteins and polynucleotides encoding them | |
| AU5840300A (en) | Glutx polypeptide family and nucleic acids encoding same | |
| AU5152700A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| KR100498658B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
| KR100528420B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
| AU2883500A (en) | Secreted proteins and polynucleotides encoding them | |
| KR100532172B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
| IL142673A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU1415401A (en) | Glmu polypeptide and dna encoding the polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |